Document is current
Any future updates will be listed below
-
Authors
Kurokawa, Miho
Goya, Takeshi
Kohjima, Motoyuki
Tanaka, Masatake
Iwabuchi, Sadahiro
Shichino, Shigeyuki
Ueha, Satoshi
Hioki, Tomonobu
Aoyagi, Tomomi
Takahashi, Motoi
Imoto, Koji
Tashiro, Shigeki
Suzuki, Hideo
Kato, Masaki
Hashimoto, Shinichi
Matsuda, Hideo
Matsushima, Kouji
Ogawa, Yoshihiro
-
Funding
Funding for this research was provided by:
Smoking Research Foundation
Japan Society for the Promotion of Science (JP20K22877, JP17K09430, JP19K17496, JP18H05039)
Takeda Science Foundation
- License Information
-
More Information
Article History
Received: 10 August 2022
Accepted: 15 April 2024
First Online: 21 June 2024
Declarations
:
: This study adhered to the Helsinki Declaration and was approved by the Ethics Committee of the Kyushu University Hospital (no. 27-377 and 2021-77). The data analysis for this study was approved by the Ethics Committee of the Kyushu University Hospital, and written informed consent was waived due to the retrospective design.
: Consents for publication were obtained from all patients.
: MKo reports research funding from Abbvie. SS reports advisory role for ImmunoGeneTeqs, Inc; stock for ImmunoGeneTeqs inc. SU reports advisory role for ImmunoGeneTeqs, Inc; stock for ImmunoGeneTeqs, Inc, IDAC Theranostics, Inc. KM reports consulting or advisory role for Kyowa-Hakko Kirin, ImmunoGeneTeqs, Inc; research funding from Kyowa-Hakko Kirin, and Ono; stock for ImmunoGeneTeqs, Inc, IDAC Theranostics, Inc. The authors are responsible for the content and writing of this article.
